Misoprostol Vaginal Insert (MVI) 100, 150, 200 mcg for Cervical Ripening and Induction of Labor
Public ClinicalTrials.gov record NCT00828711. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Dose-Ranging, Phase II Study to Assess the Efficacy and Safety of the 100, 150 and 200 mcg Misoprostol Vaginal Insert for Women Requiring Cervical Ripening and Induction of Labor
Study identification
- NCT ID
- NCT00828711
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Ferring Pharmaceuticals
- Industry
- Enrollment
- 374 participants
Conditions and interventions
Conditions
Interventions
- MVI 100 Drug
- MVI 150 Drug
- MVI 200 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2009
- Primary completion
- Nov 30, 2009
- Completion
- Nov 30, 2009
- Last update posted
- Apr 20, 2014
2009
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Precision Trials | Phoenix | Arizona | 85032 | — |
| Tuscon Medical Center | Tucson | Arizona | 85716 | — |
| Long Beach Memorial Medical Center | Long Beach | California | 90806 | — |
| UCI Medical Center | Orange | California | 92868 | — |
| University of New Mexico Medical Center | Albuquerque | New Mexico | 87131 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Forsyth Medical Center | Winston-Salem | North Carolina | 27103 | — |
| Temple University Hospital | Philadelphia | Pennsylvania | 19140 | — |
| Greenville Hospital System | Greenville | South Carolina | 29605 | — |
| University of Tennesse Medical Center | Knoxville | Tennessee | 37920 | — |
| University of Texas Health Sciences Center at Houston | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00828711, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2014 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00828711 live on ClinicalTrials.gov.